A review of the device history record (dhr) was conducted which confirmed the device met all quality criteria and manufacturing specifications prior to release.The nxstage system one user guide provide information and warnings for use of the device.The user guide warns that treatment with the nxstage system one should only be done under the responsibility of a physician and performed by a trained and qualified person.A trained and qualified person must observe all treatments, check the system for blood leaks, pay close attention to the bloodlines and access during treatment and respond promptly and appropriately to all alarms and harmful conditions during treatment.(b)(4).
|
A report was received on (b)(6) 2021 from a (b)(6) patient with a medical history of multiple comorbidities and end stage renal disease, stating the patient experienced bleeding near the access site approximately 8 minutes into a hemodialysis treatment on (b)(6) 2021 and emergency medical services (ems) were called.Additional information was received on 23 apr 2021 from the home therapy nurse (htn) stating that ems estimated a 2-liter blood loss at the scene.The patient was unresponsive and transported to the emergency department (ed), arriving in cardiac arrest due to hemorrhagic shock.In the ed, the patient was intubated and sedated.Resuscitation was performed successfully and included the facility¿s ¿massive transfusion protocol¿, achieving a return of spontaneous circulation (rosc).The patient stabilized, vascular surgery evaluated the patient¿s fistula and placed 2 sutures to achieve hemostasis.
|